Results 41 to 50 of about 13,067 (200)
Pharmacology of novel psychoactive substances [PDF]
, 2016 This PhD work consists of an in vitro and in vivo part. In the in vivo part, we investigated the role of dopamine in the acute clinical effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in healthy human subjects.
Rickli, Anna
core +1 more source
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
Frontiers in Psychiatry, 2020 Lysergic acid diethylamide (LSD) was studied from the 1950s to the 1970s to evaluate behavioral and personality changes, as well as remission of psychiatric symptoms in various disorders.
Juan José Fuentes +10 more
doaj +1 more source
Children, 2022 (1) Objectives: Hallucinogens are being explored as a potential treatment of psychiatric disorders. Micro dosing of illicitly purchased hallucinogen drugs is on the rise despite conclusive benefits.
Saral Desai +3 more
doaj +1 more source
Hallucinogens: mechanisms and medical complications [PDF]
, 2013 Thesis (M.A.)--Boston UniversityHallucinogens are drugs that alter consciousness by distorting primarily auditory and visual perception but they can affect any sensory system. Hallucinogens also affect judgment, orientation, memory, or emotion.
Chan, Ryan Harry Alexander
core
Identification of 2C-B in Hair by UHPLC-HRMS/MS. A Real Forensic Case
Toxics, 2021 The analysis of drugs of abuse in hair and other biological matrices of forensic interest requires great selectivity and sensitivity. This has been traditionally achieved through target analysis, using one or more analytical methods that include ...
José Manuel Matey +5 more
doaj +1 more source
Motives for Microdosing Hallucinogens Among College Students
, 2021 Thesis (Master's)--University of Washington, 2021Objective: Microdosing hallucinogens is generally defined as taking a small enough amount of ahallucinogen (e.g., LSD, psilocybin) with the purported intent of enchancing mood and cognition while avoiding ...
Szydlowski, Victoria
core
Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?
Medical SciencesBackground: Chronic pain affects nearly one in five adults worldwide and remains a major healthcare burden due to its persistence, multidimensional impact, and resistance to conventional therapies.
Silvia Natoli +6 more
doaj +1 more source
, 2007 SummaryHallucinogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognition, and mood. All known drugs of this class are 5-HT2A receptor (2AR) agonists, yet closely related 2AR agonists such as ...
Weisstaub, Noelia V. +23 more
core +1 more source
, 2020 A revamped interest in the study of hallucinogens has recently emerged, especially with regard to their potential application in the treatment of psychiatric disorders. In the last decade, a plethora of preclinical and clinical studies have confirmed the
Katrin H. Preller +13 more
core +2 more sources
Influence of Cannabis Decriminalisation on Consumption Patterns
Al-Sihah: The Public Health Science JournalEarlier research has frequently neglected regional consumption patterns and socio-cultural dynamics following cannabis policy shifts, particularly in low- and middle-income countries.
Ovuwa Luvhengo Munyadziwa Nethomboni +1 more
doaj +1 more source